@Genohub blog (from post #3) indicates following:
2 "lanes" for S1,S2 flowcells and 4 for S3,S4. S1,S2 only compatible with NovaSeq 5000 and S1-->S4 for NovaSeq 6000.
NovaSeq is using TWO color chemistry. Could be a concern for some.
Unconfigured Ad
Collapse
X
-
Yikes! You probably know your sales person well by now. It is possible that (s)he may not have been aware of the new sequencer until this week. At least that was my impression from some past conversations.Originally posted by kmcarr View Post@GenoMax: Yeah I agree, I was just feeling particularly crabby this AM. I'm also remembering the time we sprung for a second GAIIx only to have Illumina Announce the HiSeq a week or two after that order was booked.
With AGBT so close, it remains to be seen if we will see another major announcement there.
That is a true concern. Some institutions subsidize their cores in creative ways and competing fairly (on price) with such cores becomes very hard. Unfortunately these are things that you can't control.And while sequence is sequence regardless of instrument, $/Gbp do matter to researchers. We were loosing business because we had a 2500 as our top instrument and researchers were going elsewhere to get cheaper sequencing done on a 4000. I fear the in a year's time, when enough NovaSeq's are in the field we will be right back in the same boat.
Specs talk about 132 exomes/transcriptomes per run so perhaps the idea is to load one single pool (of many) on every run,All that said, after digging into the specs (as sparse as they are) it looks to me as though the NovaSeq flow cells are single sample, like the NextSeq. Not a single bit of the literature uses the word "lane". If that is the case then its target market isn't a core like ours. If indeed each flow cell is loaded with a single sample then it would not be a nightmare for a core like ours to coordinate multiple projects to fill up one massive sample load.if there are no independent "lanes"See next post.
Creating a big pool with compatible samples would be a headache for a core as some customers like to make their own libraries to save costs.Last edited by GenoMax; 01-10-2017, 06:34 AM.
Leave a comment:
-
@GenoMax: Yeah I agree, I was just feeling particularly crabby this AM. I'm also remembering the time we sprung for a second GAIIx only to have Illumina Announce the HiSeq a week or two after that order was booked.Originally posted by GenoMax View Post@kmcarr: Don't mean to sound mean but if you only had the budget for a 4000 then a NovaSeq would likely not have fit in it. After all sequence is sequence, no matter what sequencer model it comes from.
Having seen a string of new sequencers over the years I feel that I would rather have someone else do the bug hunting/fixing in the first year with a new instrument. It may be better to buy the sequencer in the second year, when you are much less likely to face these "growing pains".
If one is going for the "bragging rights" then there is no space for above logic.
And while sequence is sequence regardless of instrument, $/Gbp do matter to researchers. We were loosing business because we had a 2500 as our top instrument and researchers were going elsewhere to get cheaper sequencing done on a 4000. I fear the in a year's time, when enough NovaSeq's are in the field we will be right back in the same boat.
All that said, after digging into the specs (as sparse as they are) it looks to me as though the NovaSeq flow cells are single sample, like the NextSeq. Not a single bit of the literature uses the word "lane". If that is the case then its target market isn't a core like ours. If indeed each flow cell is loaded with a single sample then it would be a nightmare for a core like ours to coordinate multiple projects to fill up one massive sample load.
Leave a comment:
-
@kmcarr: Don't mean to sound mean but if you only had the budget for a 4000 then a NovaSeq would likely not have fit in it. After all sequence is sequence, no matter what sequencer model it comes from.
Having seen a string of new sequencers over the years I feel that I would rather have someone else do the bug hunting/fixing in the first year with a new instrument. It may be better to buy the sequencer in the second year, when you are much less likely to face these "growing pains".
If one is going for the "bragging rights" then there is no space for above logic.
Leave a comment:
-
Our core just bought a new 4000, and by just, I mean installed last week. Explains why Illumina was pushing us all throughout December to get the PO submitted.Originally posted by ngseq View PostWith Novaseq now on the market, who is still going to buy HiSeq 2500/3000/4000/X?
Leave a comment:
-
Small cores like ours appreciate the flexibility of the 2500, which can accommodate 16 samples per run (minimizing staff time) or two (good for uncommon sequencing requests). It's essentially a 4000 plus NextSeq in one instrument (without the limitations of two-color chemistry associated with the latter), albeit with less data output. Since many of our users already obtain more data per lane than needed (think RNA-Seq/ChIP-Seq with limited number of samples), it's an acceptable tradeoff.With Novaseq now on the market, who is still going to buy HiSeq 2500/3000/4000/X?
Leave a comment:
-
Illumina will of course say it is impossible to do the same with the current sequencers (reduce distances between nanowells).
Similar there seem to be no single end flow cells and only PE150 read kits for two the highest read number flowcells.
Leave a comment:
-
Summary of NovaSeq Specs
Biggest change is NovaSeq's reduction in space between nanowells, designed to increase cluster density and data output (up to 2-3x more per flow cell than HiSeq X). Notable is the omission of Nextera based exome and Nextera DNA library prep in the initial compatibility line up.
Summarized specs here: https://blog.genohub.com/2017/01/10/...5000-and-6000/
Leave a comment:
-
Novoseq-a terminator for ALL HiSeq platforms???
With Novaseq now on the market, who is still going to buy HiSeq 2500/3000/4000/X?
Leave a comment:
-
NovaSeq from Illumina
Illumina just announced a new type of sequencer: NovaSeq
Specifications are here.
NovaSeq 6000 - 6 Tb data/20 billion reads in 2 days
NovaSeq 5000 - 2 Tb data/1.6 billion reads in 2.5 days
Flowcells
S1,S2 - Flowcells for counting applications
For S2 - PF 1775-2070 cluster/mm^2
S3,S4 - High coverage applications
Same cartridges on both sides (three total).
Reagent Cartridge - Will take one library tube (200-300 pM) per FC
SBS Reagents - Frozen
SBS Buffers - Room temperature ship/store. Ready to use.
- FC looks huge, like NextSeq. Easy to place. No futzing needed.
- Run setup identical to current HiSeq sequencers.
- Mix/match flowcells.
- Two sides of the instrument can work independently (stream data to BaseSpace on on side, store locally on other side).
- Automatic post-run wash once sequencing is complete
- Run times includes cluster generation.
- Network speed (200 mbps)
- ONE library pool per flowcell. Lanes visually distinct but fluidically identical
- Both 5000/6000 are dual FC systems. For 5000 systems run times slightly longer
- Custom primers possible
- Asymmetric runs possible (e.g. 100 x 75)
- No "Rapid" run capability needed (Illumina's take)
- FC's can be used for single and paired-end recipes
- ExAMP, all self contained in the sequencer
- 200/240V, adequate HVAC
Test NovaSeq data is available on BaseSpace.Last edited by GenoMax; 01-24-2017, 10:05 AM.
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
10-30-2026, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
33 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
72 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: